Literature DB >> 16043417

Suppression of obsessive-compulsive symptoms after epilepsy surgery.

R Guarnieri1, D Araújo, C G Carlotti, J A Assirati, J E C Hallak, T R Velasco, V Alexandre, V C Terra-Bustamante, R Walz, M M Bianchin, L Wichert-Ana, M Linhares, C L Dalmagro, L M Inuzuka, A C Sakamoto.   

Abstract

We report two male patients with medically intractable epilepsy and obsessive-compulsive disorder (OCD) symptoms. Both patients experienced remission of obsessive-compulsive symptoms after surgical treatment of epilepsy. Although the surgeries targeted different brain regions, the two patients had in common unilateral anterior cingulate cortex ablation. On the basis of these observations, we discuss the pathophysiology of OCD symptoms, emphasizing the role of corticosubcortical pathways in their genesis. Our data suggest that surgeries that affect neural loops associated with obsessive-compulsive symptoms can lead to an improvement of OCD; however, the structures responsible for this effect cannot be conclusively determined.

Entities:  

Mesh:

Year:  2005        PMID: 16043417     DOI: 10.1016/j.yebeh.2005.05.024

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  8 in total

1.  Sub-millimeter isotropic MRI for segmentation of subcortical brain regions and brain visualization.

Authors:  Ying Wu; Ann B Ragin; Hongyan Du; Shawn Sidharthan; Eugene E Dunkle; Ioannis Koktzoglou; Robert R Edelman
Journal:  J Magn Reson Imaging       Date:  2010-04       Impact factor: 4.813

2.  Clinical treatment of obsessive compulsive disorder.

Authors:  Christopher Pittenger; Ben Kelmendi; Michael Bloch; John H Krystal; Vladimir Coric
Journal:  Psychiatry (Edgmont)       Date:  2005-11

3.  Epileptiform synchronization in the cingulate cortex.

Authors:  Gabriella Panuccio; Giulia Curia; Alfredo Colosimo; Giorgio Cruccu; Massimo Avoli
Journal:  Epilepsia       Date:  2008-10-30       Impact factor: 5.864

Review 4.  Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder.

Authors:  Christopher Pittenger; John H Krystal; Vladimir Coric
Journal:  NeuroRx       Date:  2006-01

Review 5.  Epilepsy and obsessive-compulsive disorder.

Authors:  Peter W Kaplan
Journal:  Dialogues Clin Neurosci       Date:  2010       Impact factor: 5.986

6.  The neurologist who could not stop rhyming and rapping.

Authors:  Mario F Mendez
Journal:  Neurocase       Date:  2022-01-23       Impact factor: 0.781

7.  Improvement in Obsessive-Compulsive Disorder Following Right Anterior Temporal Lobectomy and Amygdalohippocampectomy in a Patient with Refractory Temporal Lobe Epilepsy with Right Mesial Temporal Sclerosis.

Authors:  A S Shreedhara; G K Bhargava; Raghavendra Kenchaiah; C M Ravindranadh; Arivazhagan Arima; Rose Dawn Bharath; Jitender Saini; N Chandana; Jamuna Rajeswaran; Malla Bhaskara Rao; Parthasarathy Satishchandra; Y C Janardhana Reddy; Sanjib Sinha
Journal:  Ann Indian Acad Neurol       Date:  2018 Oct-Dec       Impact factor: 1.383

8.  Suppression of obsessive-compulsive symptoms after head trauma.

Authors:  Seyed Hamzeh Hosseini; Paria Azari; Roohollah Abdi; Reza Alizadeh-Navaei
Journal:  Case Rep Med       Date:  2012-08-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.